Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5202220
Max Phase: Preclinical
Molecular Formula: C40H37N11O6S
Molecular Weight: 799.87
Associated Items:
ID: ALA5202220
Max Phase: Preclinical
Molecular Formula: C40H37N11O6S
Molecular Weight: 799.87
Associated Items:
Canonical SMILES: N#CN1CC[C@@H](C(=O)Nc2nc3c(s2)CN(C(=O)Cn2cc(CCCNC(=O)c4ccc(-c5c6ccc(=N)cc-6oc6cc(N)ccc56)c(C(=O)O)c4)nn2)CC3)C1
Standard InChI: InChI=1S/C40H37N11O6S/c41-21-49-12-9-23(17-49)38(54)46-40-45-31-10-13-50(19-34(31)58-40)35(52)20-51-18-26(47-48-51)2-1-11-44-37(53)22-3-6-27(30(14-22)39(55)56)36-28-7-4-24(42)15-32(28)57-33-16-25(43)5-8-29(33)36/h3-8,14-16,18,23,42H,1-2,9-13,17,19-20,43H2,(H,44,53)(H,55,56)(H,45,46,54)/t23-/m1/s1
Standard InChI Key: OXEZGBFVTPLTOK-HSZRJFAPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 799.87 | Molecular Weight (Monoisotopic): 799.2649 | AlogP: 3.70 | #Rotatable Bonds: 11 |
Polar Surface Area: 249.45 | Molecular Species: ACID | HBA: 14 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.20 | CX Basic pKa: 7.55 | CX LogP: -0.89 | CX LogD: -1.11 |
Aromatic Rings: 4 | Heavy Atoms: 58 | QED Weighted: 0.05 | Np Likeness Score: -1.28 |
1. Jia Y, Kim RQ, Kooij R, Ovaa H, Sapmaz A, Geurink PP.. (2022) Chemical Toolkit for PARK7: Potent, Selective, and High-Throughput., 65 (19.0): [PMID:36149939] [10.1021/acs.jmedchem.2c01113] |
Source(1):